To discern if specific mutagenic processes were more likely to have caused particular KRAS alleles, the trinucleotide context of the KRAS mutation and the relative activity of the mutational signature in that tumor were used to calculate the probability that the allele in an individual tumor was caused by any detectable mutational process (Fig. 1d). Here, KRAS is linked to neoplasm.